Modafinil (6 Offers)

What Is Modafinil?

Modafinil is a prescription wakefulness-promoting agent that acts on the central nervous system. It is used medically to improve wakefulness in adults with excessive sleepiness associated with certain diagnosed sleep disorders.

Modafinil is not an anabolic steroid, hormone, SERM or aromatase inhibitor. Its pharmacology is fundamentally different from the endocrine substances found elsewhere in this catalog.

Modafinil & Provigil

Modafinil identifies the active pharmaceutical ingredient. Provigil is a well-known brand name associated with Modafinil, while generic and manufacturer-specific products can be marketed under other names.

Products with different branding may therefore contain the same active substance. Check the labeled active ingredient, tablet strength, package quantity and manufacturer when comparing available options.

How Does Modafinil Work?

Modafinil promotes wakefulness through effects on the central nervous system. Its pharmacology is complex and is not accurately described as acting through only one neurotransmitter pathway.

Evidence indicates that dopamine signaling is involved, including interaction with the dopamine transporter, while downstream effects involve additional neurotransmitter systems associated with wakefulness and arousal.

This is one reason Modafinil is generally described as a wakefulness-promoting agent rather than reducing its mechanism to that of a conventional stimulant.

Established Medical Uses of Modafinil

In the United States, Modafinil has established prescription uses for improving wakefulness in adults with excessive sleepiness associated with narcolepsy, obstructive sleep apnea and shift work disorder.

These indications involve clinically significant excessive sleepiness rather than ordinary tiredness after insufficient sleep. The underlying sleep disorder still requires appropriate evaluation and management.

For obstructive sleep apnea in particular, a wakefulness-promoting medicine does not correct the airway obstruction itself or replace treatment directed at the underlying condition.

Wakefulness vs. Normal Sleep

Modafinil can promote wakefulness, but pharmacologically increasing alertness is not equivalent to obtaining adequate restorative sleep.

Sleep supports numerous physiological processes involving cognition, metabolic regulation, immune function and physical recovery. A wakefulness-promoting medicine should therefore not be viewed as a general substitute for sleep.

Persistent excessive daytime sleepiness can also indicate an underlying sleep or medical disorder and warrants appropriate evaluation rather than simply being masked with a wakefulness-promoting substance.

Comparing Modafinil Products

When browsing Modafinil products, useful comparison points include the labeled amount per tablet, total tablet count, manufacturer, current price, warehouse location and published laboratory testing where available.

Products containing the same active ingredient can still differ in tablet strength, package quantity and manufacturer-specific branding. Reviewing the complete specification provides a clearer comparison than relying on packaging or price alone.

Tablet Strength vs. Package Quantity

The labeled mg-per-tablet strength identifies the amount of Modafinil stated in each tablet. Package quantity separately identifies the total number of tablets supplied.

Two Modafinil products can therefore contain the same active ingredient while differing in tablet strength or package quantity. Check both specifications when comparing available products.

Published Modafinil Lab Reports

Selected Modafinil products may have published laboratory reports that provide an additional reference point when comparing the labeled specification with the measured result reported for a submitted sample.

Where testing is available, review the identified active substance, measured result, testing date and reported batch number. If multiple reports have been published, results from different batches or testing dates can be reviewed individually.

Each laboratory report applies to the submitted sample identified in that analysis. A result from one sample does not independently verify every tablet, package or future production batch.

Modafinil in Fitness & Performance Contexts

Modafinil is sometimes discussed outside its established medical indications in relation to alertness, demanding work schedules, training or cognitive performance. These discussions should be distinguished from its approved medical uses for specific causes of excessive sleepiness.

Feeling more awake does not remove the physiological consequences of inadequate sleep, nor does it establish that continued wakefulness is safe. Fatigue can also be an important signal that recovery or medical evaluation is needed.

Modafinil should therefore not be viewed as a substitute for sleep, recovery or appropriate management of an underlying sleep disorder. This category provides product and safety information rather than protocols for non-medical performance use.

Modafinil Safety Information

Modafinil is a pharmacologically active prescription medicine. Reported adverse effects can include headache, nausea, nervousness, anxiety, dizziness and difficulty sleeping, among others.

Serious skin reactions and hypersensitivity reactions have also been reported. A new or concerning rash, swelling, difficulty breathing or other signs of a severe reaction require prompt medical attention.

Psychiatric effects can occur in some individuals, and particular caution may be appropriate in people with a history of certain psychiatric conditions. Cardiovascular status and other medications can also be relevant when assessing individual risk.

Modafinil can interact with other medicines by affecting drug-metabolizing enzymes. Product-specific prescribing information and potential interactions should therefore be considered rather than treating Modafinil as an ordinary energy or focus supplement.

A published laboratory report can provide information about an analyzed product sample but does not establish that taking Modafinil is medically appropriate or safe for an individual. This category is intended for product identification and comparison and does not provide individualized dosing guidance.

Modafinil & Hormonal Contraception

An important interaction associated with Modafinil involves certain steroidal hormonal contraceptives. Modafinil can reduce the effectiveness of some hormonal contraceptive methods through effects on drug-metabolizing enzymes.

This interaction can remain relevant for a period after Modafinil is discontinued. Anyone relying on hormonal contraception should review the current prescribing information and discuss appropriate contraceptive precautions with a healthcare professional.

This interaction is particularly important because it may not be obvious from the wakefulness-promoting effects of the medicine itself.

Alertness & Driving

Treatment with a wakefulness-promoting medicine does not guarantee normal alertness. Some people with sleep disorders can continue to experience excessive sleepiness even when taking medication.

Driving, operating machinery and other activities requiring sustained attention should not be assumed to be safe simply because Modafinil has been taken. Individual response and residual sleepiness remain important considerations.

Prescription & Controlled-Substance Status in the USA

In the United States, Modafinil is a prescription medicine and a Schedule IV controlled substance. Its regulatory status reflects that it is a centrally acting medicine with potential for misuse rather than an ordinary over-the-counter stimulant or dietary supplement.

Legal and prescription requirements can differ outside the United States. Product availability within an international catalog does not change the laws or import requirements that apply at the destination.

Modafinil Is Different from Hormonal Ancillaries

Unlike substances such as Anastrozole, Clomiphene or Cabergoline, Modafinil is not primarily used to modify estrogen, gonadotropin or prolactin signaling.

Its primary pharmacological context is wakefulness and the central nervous system. This distinction is useful when browsing a catalog that contains several very different types of prescription ancillary products within the same broader section.

USA Domestic & International Availability

Modafinil products may be available from the USA Domestic Warehouse, the International Warehouse, or both. Available manufacturers, tablet strengths and stock levels can differ between warehouse locations.

For delivery within the United States, USA Domestic shipments typically take 4–5 business days after dispatch, while International Warehouse shipments typically take 15–20 business days after dispatch.

Delivery estimates begin after dispatch and do not include order processing time. Additional delivery, tracking and reship information is available on the Shipping Information page.

Product & Payment Information

Bitcoin and other supported cryptocurrencies are available at checkout. When comparing Modafinil products, review the manufacturer, labeled tablet strength, package quantity, current price, available laboratory reports and warehouse location.

Payment availability does not alter prescription, controlled-substance or import requirements that may apply. Where the store's separate crypto discount applies, eligibility depends on the current pricing status of the product.